The global functional sugar market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for functional sugars in pharmaceutical industries and research applications. The increasing awareness about the benefits of functional sugars in various applications such as pharmaceuticals, food & beverages, and cosmetics is also driving the growth of this market.
The North American region accounted for a share of 34% in 2018 and is expected to grow at a CAGR of 4.8% during the forecast period, from 2021 to 2030. This can be attributed to factors such as increased awareness about health benefits associated with consumption of functional sugars and growing demand for sugar-free products among consumers in North America region.
Some Of The Growth Factors Of This Market:
- Functional sugars are used as ingredients in food products such as yogurt, cereal bars, and ice cream for their health benefits such as weight management and improved gut health.
- Functional sugars are also used in pharmaceuticals for their therapeutic benefits such as anti-inflammatory properties.
- Pharmaceutical companies are increasingly using functional sugars to improve drug efficacy.
Industry Growth Insights published a new data on “Functional Sugar for Pharmaceutical Market”. The research report is titled “Functional Sugar for Pharmaceutical Market research by Types (Oligosaccharide, Inulin, Sugar Alcohols, Others), By Applications (Pharmaceutical Industries, Research), By Players/Companies FrieslandCampina, Baolingbao, QHT, Beghin Meiji, Nikon Shikuhin KaKo, Ingredion, Nissin-sugar, Yakult, Orafit, Longlive, Taiwan Fructose, YIBIN YATAI, NFBC, Roquette, ADM”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Functional Sugar for Pharmaceutical Market Research Report
By Type
Oligosaccharide, Inulin, Sugar Alcohols, Others
By Application
Pharmaceutical Industries, Research
By Companies
FrieslandCampina, Baolingbao, QHT, Beghin Meiji, Nikon Shikuhin KaKo, Ingredion, Nissin-sugar, Yakult, Orafit, Longlive, Taiwan Fructose, YIBIN YATAI, NFBC, Roquette, ADM
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Functional Sugar for Pharmaceutical Market Report Segments:
The global Functional Sugar for Pharmaceutical market is segmented on the basis of:
Types
Oligosaccharide, Inulin, Sugar Alcohols, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceutical Industries, Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- FrieslandCampina
- Baolingbao
- QHT
- Beghin Meiji
- Nikon Shikuhin KaKo
- Ingredion
- Nissin-sugar
- Yakult
- Orafit
- Longlive
- Taiwan Fructose
- YIBIN YATAI
- NFBC
- Roquette
- ADM
Highlights of The Functional Sugar for Pharmaceutical Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oligosaccharide
- Inulin
- Sugar Alcohols
- Others
- By Application:
- Pharmaceutical Industries
- Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Functional Sugar for Pharmaceutical Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Functional sugar is a type of sugar that has been specifically designed to be used in pharmaceutical products. These sugars are often used as sweeteners or preservatives, and can help to improve the overall quality and stability of a drug product.
Some of the major players in the functional sugar for pharmaceutical market are FrieslandCampina, Baolingbao, QHT, Beghin Meiji, Nikon Shikuhin KaKo, Ingredion, Nissin-sugar, Yakult, Orafit, Longlive, Taiwan Fructose, YIBIN YATAI, NFBC, Roquette, ADM.
The functional sugar for pharmaceutical market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Functional Sugar for Pharmaceutical Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Functional Sugar for Pharmaceutical Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Functional Sugar for Pharmaceutical Market - Supply Chain
4.5. Global Functional Sugar for Pharmaceutical Market Forecast
4.5.1. Functional Sugar for Pharmaceutical Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Functional Sugar for Pharmaceutical Market Size (000 Units) and Y-o-Y Growth
4.5.3. Functional Sugar for Pharmaceutical Market Absolute $ Opportunity
5. Global Functional Sugar for Pharmaceutical Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Functional Sugar for Pharmaceutical Market Size and Volume Forecast by Type
5.3.1. Oligosaccharide
5.3.2. Inulin
5.3.3. Sugar Alcohols
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Functional Sugar for Pharmaceutical Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Functional Sugar for Pharmaceutical Market Size and Volume Forecast by Application
6.3.1. Pharmaceutical Industries
6.3.2. Research
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Functional Sugar for Pharmaceutical Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Functional Sugar for Pharmaceutical Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Functional Sugar for Pharmaceutical Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Functional Sugar for Pharmaceutical Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Functional Sugar for Pharmaceutical Demand Share Forecast, 2019-2026
9. North America Functional Sugar for Pharmaceutical Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Functional Sugar for Pharmaceutical Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Functional Sugar for Pharmaceutical Market Size and Volume Forecast by Application
9.4.1. Pharmaceutical Industries
9.4.2. Research
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Functional Sugar for Pharmaceutical Market Size and Volume Forecast by Type
9.7.1. Oligosaccharide
9.7.2. Inulin
9.7.3. Sugar Alcohols
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Functional Sugar for Pharmaceutical Demand Share Forecast, 2019-2026
10. Latin America Functional Sugar for Pharmaceutical Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Functional Sugar for Pharmaceutical Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Functional Sugar for Pharmaceutical Market Size and Volume Forecast by Application
10.4.1. Pharmaceutical Industries
10.4.2. Research
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Functional Sugar for Pharmaceutical Market Size and Volume Forecast by Type
10.7.1. Oligosaccharide
10.7.2. Inulin
10.7.3. Sugar Alcohols
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Functional Sugar for Pharmaceutical Demand Share Forecast, 2019-2026
11. Europe Functional Sugar for Pharmaceutical Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Functional Sugar for Pharmaceutical Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Functional Sugar for Pharmaceutical Market Size and Volume Forecast by Application
11.4.1. Pharmaceutical Industries
11.4.2. Research
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Functional Sugar for Pharmaceutical Market Size and Volume Forecast by Type
11.7.1. Oligosaccharide
11.7.2. Inulin
11.7.3. Sugar Alcohols
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Functional Sugar for Pharmaceutical Demand Share, 2019-2026
12. Asia Pacific Functional Sugar for Pharmaceutical Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Functional Sugar for Pharmaceutical Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Functional Sugar for Pharmaceutical Market Size and Volume Forecast by Application
12.4.1. Pharmaceutical Industries
12.4.2. Research
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Functional Sugar for Pharmaceutical Market Size and Volume Forecast by Type
12.7.1. Oligosaccharide
12.7.2. Inulin
12.7.3. Sugar Alcohols
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Functional Sugar for Pharmaceutical Demand Share, 2019-2026
13. Middle East & Africa Functional Sugar for Pharmaceutical Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Functional Sugar for Pharmaceutical Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Functional Sugar for Pharmaceutical Market Size and Volume Forecast by Application
13.4.1. Pharmaceutical Industries
13.4.2. Research
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Functional Sugar for Pharmaceutical Market Size and Volume Forecast by Type
13.7.1. Oligosaccharide
13.7.2. Inulin
13.7.3. Sugar Alcohols
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Functional Sugar for Pharmaceutical Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Functional Sugar for Pharmaceutical Market: Market Share Analysis
14.2. Functional Sugar for Pharmaceutical Distributors and Customers
14.3. Functional Sugar for Pharmaceutical Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. FrieslandCampina
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Baolingbao
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. QHT
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Beghin Meiji
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Nikon Shikuhin KaKo
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Ingredion
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Nissin-sugar
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Yakult
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Orafit
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Longlive
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Taiwan Fructose
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. YIBIN YATAI
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. NFBC
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Roquette
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. ADM
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
